Dr. Barry C. Gibney is Section Head of Thoracic Surgery at the Medical University of South Carolina and Hollings Cancer Center in Charleston, South Carolina. He specializes in leading-edge treatments and minimally invasive robotic surgery for patients diagnosed with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies. He is thankful that the development of immunotherapy
Dr. Jeremy Paul Cetnar is a medical oncologist at the Knight Cancer Institute, OHSU Health, and the OHSU School of Medicine in Portland, Oregon. As part of the lung cancer team, he meets with other oncologists, surgeons, radiation oncologists, and other healthcare professionals three times a month to discuss each patient’s case and provide them
Asbestos contamination of cosmetic talc has been blamed for numerous cases of malignant mesothelioma, ovarian cancer, asbestos-related lung cancer, and other serious illnesses. In a recent case filed in the Supreme Court of New York County, a woman diagnosed with an asbestos-related disease has named well-known companies including Avon, Chanel, and Estee Lauder for exposing
Dr. Paul H. Schipper is a cardiothoracic and thoracic surgeon with OHSU Health and a member of the lung cancer team at the Knight Cancer Institute. He specializes in chest and lung surgery, with a special focus on esophageal cancer, lung cancer, minimally invasive thoracic surgery, thymoma, and thymic malignancies. He pioneered the use of
Dr. Raid Aljumaily is a medical oncologist with a special interest in thoracic oncology. He practices at the Stephenson Cancer Center of Oklahoma University Health in the Department of Hematology/Oncology, treating patients diagnosed with lung cancer, pleural mesothelioma, and other thoracic malignancies. Dr. Aljumaily’s practice is guided by his scientific background, and he works to
Dr. Jess Schwartz is a thoracic surgeon with extensive specialty training in minimally invasive surgical techniques, including robotic and video-assisted thoracic surgery. He deploys these skills at the Stephenson Cancer Center and Oklahoma University Health in Oklahoma City, Oklahoma, caring for patients with thoracic malignancies, specializing in treating patients with lung cancer, esophageal cancer, mediastinal
Dr. J. Matthew Reinersman is a thoracic surgeon and thoracic oncologist who treats patients with lung cancer, malignant pleural mesothelioma, esophageal cancer, and other types of thoracic malignancies at the Stephenson Cancer Institute at Oklahoma University. He specializes in using robotic technology and minimally invasive surgical techniques to improve patient outcomes and minimize adverse effects.
Medical researchers are relentlessly searching for answers to the puzzle of malignant mesothelioma, the rare and deadly asbestos-related disease that has proven so resistant to traditional cancer treatments. A recent discovery by researchers in Germany has provided an important piece of the puzzle: The scientists have identified a biomarker that is both more accurate than
Dr. Kai He is an innovative medical oncologist who specializes in the care of lung cancer and malignant pleural mesothelioma patients at the James Cancer Hospital of The Ohio State University. Dr. He’s expertise lies in providing personalized care based on his patients’ unique clinical, genetic, and immunological characteristics. Dr. He is also a physician-scientist
Dr. David P. Carbone is a medical oncologist who specializes in treating patients with lung cancer and other thoracic malignancies at the James Cancer Hospital of the Ohio State University Comprehensive Cancer Center. Dr. Carbone is Director of the hospital’s thoracic center and co-leader of the Translational Therapeutics Program at the Ohio State University Comprehensive